| For: | Imbrizi M, Azevedo MFC, Baima JP, Queiroz NSF, Parra RS, Ferreira SDC, Sassaki LY, Chebli JMF. Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice. World J Gastroenterol 2025; 31(29): 107745 [PMID: 40809925 DOI: 10.3748/wjg.v31.i29.107745] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i29/107745.htm |
| Number | Citing Articles |
| 1 |
Ying Zhang, Qin Zhao, Jingcheng Miao, Jianjun Tu, Pengfei Wang, Anquan Li, Jun Li. Dynamic changes in serum gelsolin combined with clinical parameters to construct a predictive model for mucosal healing in inflammatory bowel disease: A prospective cohort study. Medicine 2026; 105(20) doi: 10.1097/MD.0000000000048832
|
| 2 |
Natália de Castro Borges, Hélio Paulo de Matos Neto, Lawani Rigopoulos, Maria Paula Ribeiro Dantas Bezerra, Maria Carolina Dias Rego, Luísa Leite Barros. Disseminated Tuberculosis With Placental Involvement in a Crohn’s Disease Patient Treated With Combination Therapy. Gastro Hep Advances 2026; 5(8) doi: 10.1016/j.gastha.2026.100998
|
| 3 |
Iago Rodríguez-Lago, Fernando Muñoz Núñez, Alfredo J. Lucendo, Alfonso De Lossada Juste, Ana Cabez, Alberto de la Cuadra-Grande, Itziar Oyagüez, Emilio Monte-Boquet. Cost-Effectiveness Analysis of Etrasimod Compared With Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain. PharmacoEconomics - Open 2026; 10(1) doi: 10.1007/s41669-025-00619-6
|